Lower Genital Tract Infections in Pregnant Women: Epidemiology and Risk Factors Associated in Dakar, Senegal

Year : 2024 | Volume :01 | Issue : 02 | Page : 47-59
By

Ndeye Safietou Ngom

Gora Lo

Assane Dieng

Doudou Georges Massar Niang

Serigne Mbaye Lo Ndiaye

Alioune Tine

Awa ba-Diallo

Omar Gassama

Halimatou Diop-Ndiaye

Makhtar Camara

Abstract

Vaginal infections are responsible for many problems in women of childbearing age and significantly influence pregnancy outcomes. This study sought to ascertain the prevalence of lower genital tract infections and the risk factors associated with them in pregnant women under observation at the Nabil Choucair Health Centre in Dakar, Senegal. This nine-month cross-sectional study, which involved women between 34 and 38 weeks gestation (WG), was carried out from July 2020 to March 2021. The vaginal samples were analyzed using the humid montage method, Gram coloration (Nugent criteria), and culture in a specific medium. The data was analyzed using SPSS version 25 and the chi-two test to determine the strength of the association. A significance level of p < 0.05 was set for the statistical tests. Microbiological confirmation of infection was found in 227 pregnant women, resulting in an overall prevalence of 59.1% (227/384). In the series, the median gestational age was 36 WG. Only 55.9% (215/384) of patients reported infection-related symptoms. With 42.7% (164/384) of these infections being vulvovaginal candidiasis, it was the most frequent, followed by bacterial vaginosis (29.2%; 112/384) and Trichomonas vaginal (1.3%; 5/384). Mixed infections were recorded at 24.8% (n = 94), with a Gardnerella vaginalis/Candida spp. co-infection rate estimated at 13.80% (n = 53). Other germs found in mixed infections included Group B Streptococcus (GBS; 8.07%; n = 31) and Escherichia coli (0.78%; n = 3). Clinical symptoms (p = 0.018), bleeding from ectocervical contacts (p = 0.005), and unfavorable pregnancy outcomes (p = 0.020) were significantly correlated with the occurrence of lower genital tract infections. Our findings show a high prevalence of vaginal infections during pregnancy. Vaginal sampling during pregnancy should be included in the prenatal surveillance program to reduce the disease burden and complications associated with lower genital tract infections.

Keywords: Lower genital infections, Pregnant women, Associated risk factors, Senegal.

[This article belongs to Recent Trends in Infectious Diseases(rtid)]

How to cite this article: Ndeye Safietou Ngom, Gora Lo, Assane Dieng, Doudou Georges Massar Niang, Serigne Mbaye Lo Ndiaye, Alioune Tine, Awa ba-Diallo, Omar Gassama, Halimatou Diop-Ndiaye, Makhtar Camara. Lower Genital Tract Infections in Pregnant Women: Epidemiology and Risk Factors Associated in Dakar, Senegal. Recent Trends in Infectious Diseases. 2024; 01(02):47-59.
How to cite this URL: Ndeye Safietou Ngom, Gora Lo, Assane Dieng, Doudou Georges Massar Niang, Serigne Mbaye Lo Ndiaye, Alioune Tine, Awa ba-Diallo, Omar Gassama, Halimatou Diop-Ndiaye, Makhtar Camara. Lower Genital Tract Infections in Pregnant Women: Epidemiology and Risk Factors Associated in Dakar, Senegal. Recent Trends in Infectious Diseases. 2024; 01(02):47-59. Available from: https://journals.stmjournals.com/rtid/article=2024/view=144733




References

  1. Bagga, R., and Arora, P. (2020). Genital Micro-Organisms in Pregnancy. Frontiers in public health, 8, 225. https://doi.org/10.3389/fpubh.2020.00225
  2. Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S., & McCulle, S. L. (2011). Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences of the United States of America, 108 Suppl 1(Suppl 1), 4680–4687. https://doi.org/10.1073/pnas.1002611107
  3. WHO Global Maternal Sepsis Study (GLOSS) Research Group. Frequency and management of maternal infections in health facilities in 52 countries (GLOSS): an initial 1-week cohort study. Lancet Glob Health. 2020;8( 5):e661-e671. doi:10.1016/S2214-109X(20)30109-1
  4. Maternal and neonatal mortality in Senegal: 315 deaths per 100,000 live births | Fonds Francais Muskoka (ffmuskoka.org) https://news.un.org/fr/story/2019/09/1052012.
  5. https://microbiologiemedicale.fr/diagnostic-infections-vaginales/ consulted on 16/06/2023.
  6. Owen, M. K., & Clenney, T. L. (2004). Management of vaginitis. American family physician, 70(11), 2125–2132.
  7. Salinas, A. M., Osorio, V. G., Endara, P. F., Salazar, E. R., Vasco, G. P., Vivero, S. G., & Machado, A. (2018). Bacterial identification of the vaginal microbiota in Ecuadorian pregnant teenagers: an exploratory analysis. PeerJ, 6, e4317. https://doi.org/10.7717/peerj.4317.
  8. Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991). Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of clinical microbiology, 29(2), 297–301. https://doi.org/10.1128/jcm.29.2.297-301.1991.
  9. Aagaard, K., Riehle, K., Ma, J., Segata, N., Mistretta, T. A., & Coarfa, C. (2012). A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PloS one, 7(6), e36466. https://doi.org/10.1371/journal.pone.0036466.
  10. Domeika, M., Zhurauskaya, L., Savicheva, A., Frigo, N., Sokolovskiy, E., Hallén, A., & Eastern European Network for Sexual and Reproductive Health (2010). Guidelines for the laboratory diagnosis of trichomoniasis in East European countries. Journal of the European Academy of Dermatology and Venereology: JEADV, 24(10), 1125–1134. https://doi.org/10.1111/j.1468-3083.2010.03601.x
  11. Froböse, N. J., Bjedov, S., Schuler, F., Kahl, B. C., Kampmeier, S., & Schaumburg, F. (2020). Gram Staining: a Comparison of Two Automated Systems and Manual Staining. Journal of clinical microbiology, 58(12), e01914-20. https://doi.org/10.1128/JCM.01914-20
  12. Matheson, A., & Mazza, D. (2017). Recurrent vulvovaginal candidiasis: A review of guideline recommendations. The Australian & New Zealand journal of obstetrics & gynaecology, 57(2), 139–145. https://doi.org/10.1111/ajo.12592.
  13. Franco-Duarte, R., Černáková, L., Kadam, S., Kaushik, K. S., Salehi, B., Bevilacqua, A., & al. (2019). Advances in Chemical and Biological Methods to Identify Microorganisms-From Past to Present. Microorganisms, 7(5), 130. https://doi.org/10.3390/microorganisms7050130.
  14. De La Rosa, M., Villareal, R., Vega, D., Miranda, C., & Martinezbrocal, A. (1983). Granada medium for detection and identification of group B streptococci. Journal of clinical microbiology, 18(4), 779–785. https://doi.org/10.1128/jcm.18.4.779-785.1983.
  15. Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991). Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of clinical microbiology, 29(2), 297–301. https://doi.org/10.1128/jcm.29.2.297-301.1991
  16. Diadhiou, M., Ba Diallo, A., Barry, M. S., Alavo, S. C., Mall, I., Gassama, O., Ndiaye Guèye, M. D & al. (2019). Prevalence and Risk Factors of Lower Reproductive Tract Infections in Symptomatic Women in Dakar, Senegal. Infectious diseases, 12, 1178633719851825. https://doi.org/10.1177/1178633719851825.
  17. Konadu, D. G., Owusu-Ofori, A., Yidana, Z., Boadu, F., Iddrisu, L. F., Adu-Gyasi, D., Dosoo, D., & al. Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana. BMC pregnancy and childbirth, 19(1), 341. https://doi.org/10.1186/s12884-019-2488-z.
  18. Dickson, S. N., Denis, Z., Jules-Clement, N. A., Anna, L. N., Che Denis Nchang, Neville MvoNgum, Weledji Elroy Patrick, and NgoweNgowe Marcelin, “The Epidemiology of Trichomonas vaginalis, Gardnerella vaginalis and Candida albicans Co- Infections in Women Attending the Yaounde University Teaching Hospital.” American Journal of Epidemiology and Infectious Disease, vol. 3, no. 2 (2015): 28-31. doi: 10.12691/ajeid-3-2-2.
  19. Majigo, M. V., Kashindye, P., Mtulo, Z., & Joachim, A. (2021). Bacterial vaginosis, the leading cause of genital discharge among women presenting with vaginal infection in Dar es Salaam, Tanzania. African health sciences, 21(2), 531–537. https://doi.org/10.4314/ahs.v21i2.7.
  20. Yasin, J., Ayalew, G., Dagnaw, M., Shiferaw, G., & Mekonnen, F. (2021). Vulvovaginitis Prevalence Among Women in Gondar, Northwest Ethiopia: Special Emphasis on Aerobic Vaginitis Causing Bacterial Profile, Antimicrobial Susceptibility Pattern, and Associated Factors. Infection and drug resistance, 14, 4567–4580. https://doi.org/10.2147/IDR.S337205
  21. Konaté, A., Yavo, W., Kassi, F. K., Djohan, V., Angora, E. K., Barro-Kiki, P. C., Bosson-Vanga, H., Soro, F., & Menan, E. I. (2014). Aetiologies and contributing factors of vulvovaginal candidiasis in Abidjan (Cote d’Ivoire). Journal de mycologie medicale, 24(2), 93–99. https://doi.org/10.1016/j.mycmed.2013.11.006.
  22. Fanou, B. A., Klotoe, J. R., Dougnon, V., Monteiro, A., Koudokpon, C. H., & Loko, F. (2022). Prevalence and factors associated with vulvovaginal candidiasis in women admitted to the Zone Hospital of Mènontin (Bénin). The Pan African medical journal, 42, 215. https://doi.org/10.11604/pamj.2022.42.215.28984
  23. Bitew, A., & Abebaw, Y. (2018). Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC women’s health, 18(1), 94. https://doi.org/10.1186/s12905-018-0607-z.
  24. Elfeky, D.S., Gohar, N.M., El-Seidi, E.A., Ezzat, M., & AboElew, S.H. (2016). Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis. Alexandria Journal of Medicine, 52, 269 – 277.
  25. Anh, D. N., Hung, D. N., Tien, T. V., Dinh, V. N., Son, V. T., Luong, N. V., & al. (2021). Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge in symptomatic non-pregnant women of childbearing age in a tertiary care hospital, Vietnam. Infectious diseases BMC, 21(1), 523. https://doi.org/10.1186/s12879-021-06192-7.
  26. Sylla K, Sow D, Lakhe NA, Tine RC, Dia M, Lelo S et al. Vulvo-vaginal candidiasis in the Parasitology-Mycology laboratory of the Centre Hospitalier Universitaire de Fann, Dakar (Senegal). Rev Cames Santé. 2018;5(2): 21-27 G. PubMed| Google Scholar.
  27. Osman Mohamed, A., Suliman Mohamed, M., Hussain Mallhi, T., Abdelrahman Hussain, M., Ali Jalloh, M., Ali Omar, K., & al. (2022). Prevalence of vulvovaginal candidiasis among pregnant women in Africa: A systematic review and meta-analysis. Journal of infection in developing countries, 16(8), 1243–1251. https://doi.org/10.3855/jidc.15536.
  28. Sy, O., Diongue, K., Ahmed, C. B., Ba, O., Moulay, F. C., Lo, B., & Ndiaye, D. (2018). Vulvovaginal candidiasis in pregnant women in the Mère et Enfant Hospital center in Nouakchott, Mauritania. Journal de mycologie medicale, 28(2), 345–348. https://doi.org/10.1016/j.mycmed.2018.02.006.
  29. Sangaré, I., Sirima, C., Bamba, S., Zida, A., Cissé, M., Bazié, W. W., Sanou, S., Dao, B., Menan, H., & Guiguemdé, R. T. (2018). Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso. Journal de mycologie medicale, 28(1), 186–192. https://doi.org/10.1016/j.mycmed.2017.08.006.
  30. Djohan, V., Angora, K. E., Vanga-Bosson, A. H., Konaté, A., Kassi, K. F., Kiki-Barro, P. C. M., Bedia-Tanoh, A. V., Miezan, S., Menan, E. I. H., & Yavo, W. (2019). Recurrent vulvo-vaginal candidiasis in Abidjan (Côte d’Ivoire): Aetiology and associated factors. Journal de mycologie medicale, 29(2), 127–131. https://doi.org/10.1016/j.mycmed.2019.04.002.
  31. Leli, C., Mencacci, A., Meucci, M., Bietolini, C., Vitali, M., Farinelli, S., D’ Alò, F., Bombaci, J. C., Perito, S., & Bistoni, F. (2013). Association of pregnancy and Candida vaginal colonization in women with or without symptoms of vulvovaginitis. Minerva ginecologica, 65(3), 303–309.
  32. Schuster HJ, de Jonghe BA, Limpens J, budding A. AE, Painter RC. Asymptomatic vaginal Candida colonization and adverse pregnancy outcomes, including preterm birth: a systematic review and meta-analysis. Am J Obstet Gynecol 2020;2(3):100163.
  33. Sule-Odu, A. O., Akadri, A. A., Oluwole, A. A., Osinupebi, O. A., Andu, B. A., Akiseku, A. K., & Lawal, A. I. (2020). Vaginal Candida infection in pregnancy and its implications for fetal well-being. African journal of reproductive health, 24(3), 33–40. https://doi.org/10.29063/ajrh2020/v24i3.4
  34. Mtibaa, L., Fakhfakh, N., Kallel, A., Belhadj, S., Belhaj Salah, N., Bada, N., & Kallel, K. (2017). Vulvovaginal candidiasis: Etiology, symptomatology and risk factors. Journal de mycologie medicale, 27(2), 153–158. https://doi.org/10.1016/j.mycmed.2017.01.003.
  35. Bonneton, M., Huynh, B. T., Seck, A., Bercion, R., Sarr, F. D., Delarocque-Astagneau, E., & Vray, M. (2021). Bacterial vaginosis and other infections in pregnant women in Senegal. BMC infectious diseases, 21(1), 1090. https://doi.org/10.1186/s12879-021-06767-4.
  36. Kamga, Y. M., Ngunde, J. P., & Akoachere, J. K. T. (2019). Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care at the Kumba Health District (KHD), Cameroon. BMC pregnancy and childbirth, 19(1), 166. https://doi.org/10.1186/s12884-019-2312-9.
  37. Abdul-Aziz, M., Mahdy, M. A. K., Abdul-Ghani, R., Alhilali, N. A., Al-Mujahed, L. K. A., Alabsi, S. A& al. (2019). Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana’a city, Yemen. BMC infectious diseases, 19(1), 879. https://doi.org/10.1186/s12879-019-4549-3.
  38. Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007). The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sexually transmitted diseases, 34(11), 864–869. https://doi.org/10.1097/OLQ.0b013e318074e565.
  39. Tine, R. C., Sylla, K., Ka, R., Dia, L., Sow, D., Lelo, S., & al. (2019). A study of Trichomonas vaginalis infection and correlates in women with vaginal discharge referred to Fann University Hospital, Senegal. Journal of parasitology research, 2019, 2069672. https://doi.org/10.1155/2019/2069672
  40. Abdullahi, B. and Danyaya, R. (2021): Prevalence of Candida Albicans and Trichomonas vaginalis Infection among Women Presenting With Vaginitis in Jama’a Hospital, Samaru, Zaria, Nigeria BJMLS. 6(2):69 – 77.
  41. Abdul-Aziz, M., Mahdy, M.A.K., Abdul-Ghani, R. et al. Bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis among women of reproductive age seeking primary health care in Sana’a City, Yemen. BMC Infect Dis 19, 879 (2019). https://doi.org/10.1186/s12879-019-4549-3
  42. Zenebe, M. H., Mekonnen, Z., Loha, E., & Padalko, E. (2021). Prevalence, risk factors and association with delivery outcomes of curable sexually transmitted infections among pregnant women in southern Ethiopia. PloS one, 16(3), e0248958. https://doi.org/10.1371/journal.pone.0248958
  43. Rowley, J., Vander Hoorn, S., Korenromp, E., Low, N., Unemo, M., Abu-Raddad, L. J., Chico, R. M., Smolak, A., & al. (2019). Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bulletin of the World Health Organization, 97(8), 548–562P. https://doi.org/10.2471/BLT.18.228486.
  44. Van Gerwen, O. T., & Muzny, C. A. (2019). Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis F1000Research, 8, F1000 Faculty Rev-1666. https://doi.org/10.12688/f1000research.19972.1.
  45. Fanou, B. A., Klotoe, J. R., Dougnon, V., Monteiro, A., Koudokpon, C. H., & Loko, F. (2022). Prevalence and factors associated with vulvovaginal candidiasis in women admitted to the Zone Hospital of Mènontin (Bénin)]. The Pan African medical journal, 42, 215. https://doi.org/10.11604/pamj.2022.42.215.28984.
  46. Sylla K, Sow D, Lakhe NA, Tine RC, Dia M, Lelo S et al. Vulvo-vaginal candidiasis in the Parasitology-Mycology laboratory of the Centre Hospitalier Universitaire de Fann, Dakar (Senegal). Rev Cames Santé. 2018;5(2): 21-27 G.

Regular Issue Subscription Original Research
Volume 01
Issue 02
Received February 8, 2024
Accepted March 8, 2024
Published May 1, 2024